Don't expect to feel dramatically different
Tirzepatide as a Dual GIP/GLP-1 Receptor Agonist Tirzepatide is unique because it activates two metabolic hormone pathways at once: GLP-1 (glucagon-like peptide-1): Helps regulate appetite, slows gastric emptying, improves insulin secretion, and reduces post-meal blood sugar spikes
Participation in a regulated UK clinical trial may be an option for some individuals
Monitoring your health while using a GLP-1 receptor agonist is important, and certain symptoms or situations, such as the ones below, should prompt a consultation with a doctor: New or worsening gastrointestinal symptoms, such as persistent nausea, vomiting, diarrhoea, or signs of dehydration 7 , 27
Our pharmacists can help by administering vitamin B12 injections